Rothschild & Co Asset Management US’s Exact Sciences EXAS Stock Holding History

Rothschild & Co Asset Management US’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2.92M	Sell	58,975 -7,509	-11%	-$307K	0.04%	214
2022 Q3	$2.16M	Sell	66,484 -9,836	-13%	-$406K	0.04%	226
2022 Q2	$3.01M	Sell	76,320 -4,771	-6%	-$255K	0.05%	219
2022 Q1	$5.67M	Sell	81,091 -23,428	-22%	-$1.71M	0.07%	191
2021 Q4	$8.13M	Buy	104,519 +12,724	+14%	+$1.12M	0.1%	193
2021 Q3	$8.76M	Sell	91,795 -7,078	-7%	-$747K	0.11%	188
2021 Q2	$12.3M	Sell	98,873 -11,174	-10%	-$1.33M	0.15%	171
2021 Q1	$14.5M	Sell	110,047 -49,723	-31%	-$6.81M	0.18%	158
2020 Q4	$21.2M	Sell	159,770 -35,131	-18%	-$4.25M	0.27%	129
2020 Q3	$19.9M	Sell	194,901 -39,708	-17%	-$3.43M	0.36%	122
2020 Q2	$20.4M	Sell	234,609 -29,857	-11%	-$2.39M	0.3%	138
2020 Q1	$15.3M	Buy	+264,466	New	+$21.5M	0.24%	160

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Rothschild & Co Asset Management US's EXAS Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its Exact Sciences (EXAS) stake by 11% in Q4 2022, selling an estimated $307K and leaving 58,975 shares worth $2.92M. The position accounts for 0.04% of the portfolio, ranked #214.

Rothschild & Co Asset Management US first reported a position in EXAS in Q1 2020 and has held it in 12 quarters since. The position peaked at $21.2M in Q4 2020. 552 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

Rothschild & Co Asset Management US held 58,975 shares of Exact Sciences worth $2.92M as of Q4 2022.
Rothschild & Co Asset Management US sold 7,509 Exact Sciences shares in Q4 2022, an estimated $307K.
Exact Sciences made up 0.04% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #214 holding.
Rothschild & Co Asset Management US first reported a position in Exact Sciences in Q1 2020 and has held it in 12 quarters since.
Rothschild & Co Asset Management US's Exact Sciences position peaked at $21.2M in Q4 2020.
552 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.